Don Milligan

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials

Stefano Pasquali, J D Maqueo, Jorge Espino Vela et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1998 · 473 citations

Medicine, Oncology, Pharmacology +16

A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · Blood · 2015 · 295 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +5

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

José Antonio Pérez‐Simón, Panagiotis Kottaridis, Rodrigo Martino et al. · Blood · 2002 · 244 citations · Full text

Life Sciences, Hematology, Immunology +16

Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma

Kirsty Thomson, Emma Morris, Adrian Bloor et al. · Journal of Clinical Oncology · 2008 · 166 citations · Full text

Medicine, Immunology, Oncology +13

Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia

David Oscier, Claire Dearden, Efrem Eren et al. · British Journal of Haematology · 2012 · 161 citations · Full text

Medicine, Hematology, Oncology +14